share_log

Canaccord Genuity Reiterates Buy on Biodesix, Maintains $3.5 Price Target

Canaccord Genuity Reiterates Buy on Biodesix, Maintains $3.5 Price Target

Canaccord Genuity 重申买入 Biodesix,维持3.5美元的目标价
Benzinga ·  2023/12/07 10:46

Canaccord Genuity analyst Kyle Mikson reiterates Biodesix (NASDAQ:BDSX) with a Buy and maintains $3.5 price target.

Canaccord Genuity分析师凯尔·米克森重申了Biodesix(纳斯达克股票代码:BDSX)的买入并维持3.5美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发